← Open Payments lookup

JAMI VONDIELINGEN: Open Payments

NPI 1255972006 · SEYMOUR, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,027 in 35 payments from 11 companies in 2025. Trend: 2023 $688 · 2024 $707 · 2025 $1,027

Food & beverage: $1,027
CompanyPaymentsAmount
Novo Nordisk Inc10$369
AstraZeneca Pharmaceuticals LP6$318
ABBVIE INC.5$113
GlaxoSmithKline, LLC.5$79
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$69
Novartis Pharmaceuticals Corporation1$18
Antares Pharma, Inc.1$16
Esperion Therapeutics, Inc.1$16
Otsuka America Pharmaceutical, Inc.1$14
Organon LLC1$12

Products named: Ozempic, BEVESPI AEROSPHERE, BREZTRI, VRAYLAR, CAPLYTA, Rybelsus, TRELEGY ELLIPTA, LINZESS.

Industry payments across IN — which companies pay providers there.